Terms: = Endocrine gland cancer AND POLE, POLE1, 5426, FLJ21434, DKFZp434F222, ENSG00000177084 AND Treatment
86 results:
1. Persistent hypercalcaemia associated with two pathogenic variants in the
Leszczyńska D; Szatko A; Latocha J; Kochman M; Duchnowska M; Wójcicka A; Misiorowski W; Zgliczyníski W; Glinicki P
Front Endocrinol (Lausanne); 2024; 15():1355916. PubMed ID: 38665259
[TBL] [Abstract] [Full Text] [Related]
2. Transient severe haemodynamic disturbance during radical nephrectomy: a probable catecholamine surge.
Ramalingam S; Srinivasan P
BMJ Case Rep; 2024 Apr; 17(4):. PubMed ID: 38599794
[TBL] [Abstract] [Full Text] [Related]
3. The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial.
Giudice E; Huang TT; Nair JR; Zurcher G; McCoy A; Nousome D; Radke MR; Swisher EM; Lipkowitz S; Ibanez K; Donohue D; Malys T; Lee MJ; Redd B; Levy E; Rastogi S; Sato N; Trepel JB; Lee JM
Nat Commun; 2024 Mar; 15(1):2805. PubMed ID: 38555285
[TBL] [Abstract] [Full Text] [Related]
4. Exploring Co-occurring pole Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor Mutagenicity.
Shah SM; Demidova EV; Ringenbach S; Faezov B; Andrake M; Gandhi A; Mur P; Viana-Errasti J; Xiu J; Swensen J; Valle L; Dunbrack RL; Hall MJ; Arora S
Cancer Res Commun; 2024 Jan; 4(1):213-225. PubMed ID: 38282550
[TBL] [Abstract] [Full Text] [Related]
5. Predictive and prognostic biomarkers in female genital tract tumours: an update highlighting their clinical relevance and practical issues.
Wong RW; Cheung ANY
Pathology; 2024 Mar; 56(2):214-227. PubMed ID: 38212229
[TBL] [Abstract] [Full Text] [Related]
6. Incidence and risk factors for occult lesions in low-risk papillary thyroid microcarcinoma patients with tumor characteristics appropriate for thermal ablation: A retrospective study.
Jin L; Zhu K; Xu C; Lu J; Huang L
Medicine (Baltimore); 2023 Sep; 102(38):e34938. PubMed ID: 37746968
[TBL] [Abstract] [Full Text] [Related]
7. Factors of Central Lymph Node Metastasis in Papillary Thyroid cancer Based on C-TIRADS Analysis.
Huang W; Chen D; Zhong M; Ye J; Zhi Z; Xiao Y; Zhong Y
Horm Metab Res; 2023 Sep; 55(9):585-591. PubMed ID: 37500084
[TBL] [Abstract] [Full Text] [Related]
8. Identification of BRAF, CCND1, and MYC mutations in a patient with multiple primary malignant tumors: a case report and review of the literature.
Liu Z; Jin C; Zhang Y; Jiang Y; Wang J; Zheng L
World J Surg Oncol; 2023 May; 21(1):158. PubMed ID: 37221610
[TBL] [Abstract] [Full Text] [Related]
9. Left parathyroid carcinoma with secondary hyperparathyroidism: a case report.
Yokoyama K; Suganuma N; Rino Y
BMC Endocr Disord; 2023 May; 23(1):108. PubMed ID: 37193977
[TBL] [Abstract] [Full Text] [Related]
10. Lymph Node Posterior to the Right Recurrent Laryngeal Nerve Metastasis in Right Lobe T1a Papillary Thyroid Carcinoma: A Retrospective Cohort Study.
Yang H; Tao L
Cancer Control; 2023; 30():10732748221149819. PubMed ID: 36747345
[TBL] [Abstract] [Full Text] [Related]
11. Isolated adrenocorticotropic hormone deficiency and sialadenitis associated with nivolumab: a case report.
Simeni Njonnou SR; Aspeslagh S; Ntsama Essomba MJ; Racu ML; Kemta Lekpa F; Vandergheynst F
J Med Case Rep; 2022 Dec; 16(1):456. PubMed ID: 36482425
[TBL] [Abstract] [Full Text] [Related]
12. Oncological and functional outcomes after testis-sparing surgery in patients with germ cell tumors: a systematic review of 285 cases.
Grogg JB; Dursun ZH; Beyer J; Eberli D; Poyet C; Hermanns T; Fankhauser CD
World J Urol; 2022 Sep; 40(9):2293-2303. PubMed ID: 35821265
[TBL] [Abstract] [Full Text] [Related]
13. The Prognosis of Skip Metastasis in Papillary Thyroid Microcarcinoma Is Better Than That of Continuous Metastasis.
Weng HY; Yan T; Qiu WW; Fan YB; Yang ZL
J Clin Endocrinol Metab; 2022 May; 107(6):1589-1598. PubMed ID: 35213704
[TBL] [Abstract] [Full Text] [Related]
14. Vogt-Koyanagi-Harada syndrome-like uveitis after nivolumab administration as a treatment for ovarian cancer.
Hwang GE; Lee JW; Jeon S; Cho IH; Kim HD
Doc Ophthalmol; 2022 Apr; 144(2):153-162. PubMed ID: 34997406
[TBL] [Abstract] [Full Text] [Related]
15. A new prediction model for lateral cervical lymph node metastasis in patients with papillary thyroid carcinoma: Based on dual-energy CT.
Zou Y; Sun S; Liu Q; Liu J; Shi Y; Sun F; Gong Y; Lu X; Zhang X; Xia S
Eur J Radiol; 2021 Dec; 145():110060. PubMed ID: 34839216
[TBL] [Abstract] [Full Text] [Related]
16. Functional pre-therapeutic evaluation by genome editing of variants of uncertain significance of essential tumor suppressor genes.
Billaud A; Chevalier LM; Augereau P; Frenel JS; Passot C; Campone M; Morel A
Genome Med; 2021 Nov; 13(1):174. PubMed ID: 34749799
[TBL] [Abstract] [Full Text] [Related]
17. A peculiar manifestation and clinical course of occult primary hyperparathyroidism: a case report.
Loderer T; Rossini M; Cozzani F; Bonati E; Del Rio P
Acta Biomed; 2021 Apr; 92(S1):e2021155. PubMed ID: 33944838
[TBL] [Abstract] [Full Text] [Related]
18. Idiopathic Hypoparathyroidism With Papillary Thyroid Carcinoma in a Young Male: A Rare Case Report.
Chen W; Chen L; Wei T; Li Z; Lei J; Zhu J
Front Endocrinol (Lausanne); 2020; 11():569308. PubMed ID: 33384661
[TBL] [Abstract] [Full Text] [Related]
19. [Successful surgical treatment of a rare, large adrenal hemangioma].
Ottlakán A; Paszt A; Tiszlavicz L; Vas M; Vass C; Lázár G
Orv Hetil; 2020 Nov; 161(47):2006-2010. PubMed ID: 33226356
[TBL] [Abstract] [Full Text] [Related]
20. Airway obstruction as the primary manifestation of infantile thyroid hemangioma.
Liang Y; Pu R; Huang X; Li S; Chen Y; Tang W
Ital J Pediatr; 2020 Oct; 46(1):157. PubMed ID: 33076956
[TBL] [Abstract] [Full Text] [Related]
[Next]
